Breast cancer in patients carrying a germ-line CHEK2 mutation: Outcome after breast conserving surgery and adjuvant radiotherapy

Radiotherapy and Oncology

Volumn 82, Issue 3, 2007, Pages 349-353

  Meyer, Andreas ^a   Dörk, Thilo ^b   Sohn, Christof ^b,c   Karstens, Johann H ^a   Bremer, Michael ^a  

^a Department of Radiation Oncology ^*

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

ATM; Breast cancer; CHEK2 germline mutation; Metastasis free survival

Indexed keywords

CHECKPOINT KINASE 2; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE MUTATION; HETEROZYGOSITY; HUMAN; METASTASIS; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION MAPPING;

ADULT; AGED; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PROTEIN-SERINE-THREONINE KINASES; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33847670113     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.12.002     Document Type: Article

References (29)

1. Ahn J., Urist M., and Prives C. The Chk2 protein kinase. DNA Repair 3 (2004) 1039-1047
2. Antoniou A.C., Pharoah P.D., McMullan G., et al. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 86 (2002) 76-83
3. Bartek J., Falck J., and Lukas J. CHK2 kinase - a busy messenger. Nat Rev Mol Cell Biol 2 (2001) 877-886
4. Bartek J., and Lukas J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3 (2003) 421-429
5. Bogdanova N., Enssen-Dubrowinskaja N., Feshchenko S., et al. Association of two mutations in the CHEK2 gene with breast cancer. Int J Cancer 116 (2005) 263-266
6. Broeks A., de Witte L., Nooijen A., et al. Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers. Breast Cancer Res Treat 83 (2004) 91-93
7. Buchholz T.A., Weil M.M., Ashorn C.L., et al. Ser49Cys variant in the ataxia telangiectasia, mutated, gene that is more common in patients with breast carcinoma compared with population controls. Cancer 100 (2004) 1345-1351
8. CHEK2 Breast Cancer Case-Control Consortium. CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. Am J Hum Genet 2004;74:1175-821.
9. Cybulski C., Gorski B., Huzarski T., et al. CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet 75 (2004) 1131-1135
10. de Bock G.H., Schutte M., Krol-Warmerdam E.M., et al. Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant. J Med Genet 41 (2004) 731-735
11. Dörk T., Bendix R., Bremer M., et al. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. Cancer Res 61 (2001) 7608-7615
12. Falck J., Mailand N., Syljuasen R.G., Bartek J., and Lukas J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410 (2001) 842-847
13. Gorski B., Cybulski C., Huzarski T., et al. Breast cancer predisposing alleles in Poland. Breast Cancer Res Treat 92 (2005) 19-24
14. Haber D. Roads leading to breast cancer. N Engl J Med 343 (2000) 1566-1568
15. Huzarski T., Cybulski C., Domagala W., et al. Pathology of breast cancer in women with constitutional CHEK2 mutations. Breast Cancer Res Treat 90 (2005) 187-189
16. Johnson N., Fletcher O., Naceur-Lombardelli C., dos Santos Silva I., Ashworth A., and Peto J. Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes: a familial study. Lancet 366 (2005) 1554-1557
17. Kilpivaara O., Bartkova J., Eerola H., et al. Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients. Int J Cancer 113 (2005) 575-580
18. Kilpivaara O., Vahteristo P., Falck J., et al. CHEK2 variant I157T may be associated with increased breast cancer risk. Int J Cancer 111 (2004) 543-547
19. Matsuoka S., Rotman G., Ogawa A., Shiloh Y., Tamai K., and Elledge S.J. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc Natl Acad Sci USA 97 (2000) 10389-10394
20. Meijers-Heijboer H., van den Ouweland A., Klijn J., et al. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31 (2002) 55-59
21. Meyer A., John E., Dörk T., Sohn C., Karstens J.H., and Bremer M. Breast cancer in female carriers of ATM gene alterations: outcome of adjuvant radiotherapy. Radiother Oncol 72 (2004) 319-323
22. Pharoah P.D., Antoniou A., Bobrow M., Zimmern R.L., Easton D.F., and Ponder B.A. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31 (2002) 33-36
23. Ramos J.M., Ruiz A., Colen R., Lopez I.D., Grossman L., and Matta J.L. DNA repair and breast carcinoma susceptibility in women. Cancer 100 (2004) 1352-1357
24. Shaag A., Walsh T., Renbaum P., et al. Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish population. Hum Mol Genet 14 (2005) 555-563
25. Shieh S.Y., Ahn J., Tamai K., Taya Y., and Prives C. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev 14 (2000) 289-300
26. Teraoka S.N., Malone K.E., Doody D.R., et al. Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history. Cancer 92 (2001) 479-487
27. Vahteristo P., Bartkova J., Eerola H., et al. A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 71 (2002) 432-438
28. Venkitaraman A.R. A growing network of cancer susceptibility genes. N Engl J Med 348 (2003) 1917-1919
29. Walsh T., Casadei S., Coats K.H., et al. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 295 (2006) 1379-1388